STOCK TITAN

Scilex gets Nasdaq notice over $35M listing minimum

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Scilex Holding Co. received notice from Nasdaq that its market value of listed securities was below the $35 million minimum for 30 consecutive business days, from October 6, 2026, through November 16, 2026. It also did not meet Nasdaq’s alternative continued-listing standards for stockholders’ equity or net income from continuing operations.

The notice does not immediately affect listing or trading; Scilex’s common stock and publicly traded warrants continue to trade on the Nasdaq Capital Market. Scilex has 180 calendar days, through May 17, 2027, to regain compliance. If its market value closes at $35 million or more for at least 10 consecutive business days before then, Nasdaq will confirm compliance, though it may require a longer period, generally no more than 20 consecutive business days. If Scilex does not regain compliance by May 17, 2027, its securities would be subject to delisting, which the company could appeal. Scilex said it is evaluating options but cannot assure it will regain compliance on time.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Major point. Forward-looking: it has not happened yet and may not happen.Noncompliance by May 17, 2027 could make Scilex securities subject to delisting
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Minimum market value of listed securities $35 million Nasdaq continued-listing requirement; Scilex’s market value was below this level for 30 consecutive business days.
Period below minimum market value 30 consecutive business days From October 6, 2026, through November 16, 2026.
Compliance period 180 calendar days Scilex has until May 17, 2027, to regain compliance.
Consecutive-business-day threshold 10 consecutive business days Market value must close at $35 million or more during this period for Nasdaq to confirm compliance.
Potential extended compliance period Generally no more than 20 consecutive business days Nasdaq may require a period longer than 10 consecutive business days to determine compliance.
market value of the Company’s listed securities financial
"the market value of the Company’s listed securities (“MVLS”) was below"
MVLS Requirement regulatory
"minimum of $35 million required for continued listing"
Nasdaq Capital Market regulatory
"continue to trade on the Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
stockholders’ equity financial
"relating to minimum stockholders’ equity"
Stockholders’ equity is the portion of a company’s value that belongs to its owners after subtracting what the company owes from what it owns — like the equity in a house after paying the mortgage. For investors it shows the company’s net worth and can indicate financial strength, a cushion against losses, and the amount potentially available to support dividends or reinvestment; tracking changes helps assess whether the business is building or eroding owner value.
net income from continuing operations financial
"net income from continuing operations, respectively"
Net income from continuing operations is the profit a company earns from its ongoing, day-to-day business after paying costs, interest and taxes, excluding results from businesses it has sold or closed and one-time gains or losses. Investors care because it shows the company's recurring earning power—like comparing a regular paycheck to a one-off bonus—and gives a clearer picture of sustainable profits used to value the business and judge management performance.
Nasdaq Hearings Panel regulatory
"may appeal the delisting determination to a Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Scilex (SCLX) receive a Nasdaq deficiency notice?

Scilex received the notice because its market value of listed securities was below Nasdaq’s $35 million minimum for 30 consecutive business days, from October 6 through November 16, 2026. It also did not meet the alternative continued-listing standards for stockholders’ equity or net income from continuing operations.

When does Scilex (SCLX) have to regain Nasdaq compliance?

Scilex has until May 17, 2027, to regain compliance. Nasdaq will confirm compliance if, before that date, the company’s market value closes at $35 million or more for at least 10 consecutive business days. Nasdaq may require a longer period, generally no more than 20 consecutive business days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false00018201900001820190sclx:WarrantsToPurchaseOneShareOfCommonStockEachAtAnExercisePriceOf40250PerShareMember2026-11-172026-11-1700018201902026-11-172026-11-170001820190sclx:CommonStockParValue00001PerShare2Member2026-11-172026-11-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_______________________

FORM 8-K
_______________________

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 17, 2026

_______________________

SCILEX HOLDING COMPANY
(Exact name of registrant as specified in its charter)

_______________________

Delaware
(State or other jurisdiction
of incorporation)

001-39852
(Commission
File Number)

92-1062542
(IRS Employer
Identification No.)

 

960 San Antonio Road, Palo Alto, California, 94303
(Address of principal executive offices, including zip code)

(650) 516-4310

Registrant’s telephone number, including area code

N/A
(Former Name or Former Address, if Changed Since Last Report)

_______________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

 

☐

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

 

☐

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

 

☐

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

(Title of each class)

(Trading Symbol)

(Name of exchange on which registered)

Common Stock, par value $0.0001 per share

SCLX

The Nasdaq Stock Market LLC

Warrants to purchase one share of common stock, each at an exercise price of $397.89

SCLXW

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 


 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On November 17, 2026, Scilex Holding Company (the “Company”) was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that, for the 30 consecutive business days from October 6, 2026 through November 16, 2026, the market value of the Company’s listed securities (“MVLS”) was below the minimum of $35 million required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Requirement,” and such notice, the “Notice”). The Notice also indicated that the Company does not meet the alternative continued listing standards under Nasdaq Listing Rules 5550(b)(1) and 5550(b)(3), relating to minimum stockholders’ equity and net income from continuing operations, respectively.

The Notice has no immediate effect on the listing or trading of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), or the Company’s publicly-traded warrants to purchase Common Stock, which continue to trade on the Nasdaq Capital Market under the symbols “SCLX” and “SCLXW,” respectively.

In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided a compliance period of 180 calendar days, or until May 17, 2027 (the “Compliance Date”), to regain compliance with the MVLS Requirement. If, at any time before the Compliance Date, the Company’s MVLS closes at $35 million or more for a minimum of ten consecutive business days, Nasdaq will provide written confirmation of compliance and the matter will be closed. Nasdaq may, in its discretion, require the Company to satisfy the MVLS Requirement for a period in excess of ten consecutive business days, but generally no more than 20 consecutive business days, before determining that the Company has demonstrated an ability to maintain long-term compliance.

If the Company does not regain compliance by the Compliance Date, Nasdaq will provide written notification that the Company’s securities are subject to delisting, at which time the Company may appeal the delisting determination to a Nasdaq Hearings Panel.

The Company intends to monitor its MVLS and is evaluating available options to regain compliance with the MVLS Requirement. However, there can be no assurance that the Company will be able to timely regain compliance with the MVLS Requirement by the Compliance Date.

2

 


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

SCILEX HOLDING COMPANY

 

 

 

 

By:

/s/ Stephen Ma

 

Name:

Stephen Ma

Date: November 20, 2026

Title:

Senior Vice President, Chief Operating Officer and Chief Financial Officer

 

3

 


Filing Exhibits & Attachments

1 document

Keep reading